ET
RYTM icon

Entropy Technologies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Entropy Technologies’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
12,077
+1,759
+17% +$159K 0.05% 433
2026
Q1 		$897K Buy
10,318
+7,826
+314% +$761K 0.04% 439
2025
Q4 		$267K Sell
2,492
-6,010
-71% -$638K 0.01% 734
2025
Q3 		$859K Buy
+8,502
New +$789K 0.06% 363
2025
Q2 		– Sell
-5,502
Closed -$291K – 987
2025
Q1 		$291K Buy
+5,502
New +$305K 0.03% 545

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Entropy Technologies's RYTM Position: Q2 2026 in Review

Entropy Technologies increased its Rhythm Pharmaceuticals (RYTM) stake by 17% in Q2 2026, buying an estimated $159K and bringing the position to 12,077 shares worth $1.34M. The position accounts for 0.05% of the portfolio, ranked #433.

Entropy Technologies first reported a position in RYTM in Q1 2025 and has held it in 5 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Entropy Technologies held 12,077 shares of Rhythm Pharmaceuticals worth $1.34M as of Q2 2026.
  • Entropy Technologies bought 1,759 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $159K.
  • Rhythm Pharmaceuticals made up 0.05% of Entropy Technologies's portfolio in Q2 2026, its #433 holding.
  • Entropy Technologies first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.